Bellevue Group

Generative artificial intelligence (GenAI) drives unprecedented technological change, particularly in healthcare, offering major opportunities for businesses and investors.

The Bellevue Healthcare ETF combines active management with global healthcare expertise, delivering efficiency and transparency.

The Bellevue Healthcare fund invests in healthcare sectors, including pharmaceuticals, biotech, and medical technology.

The healthcare sector is among the most dynamic and fastest-growing industries today, driven by aging populations in Western countries and rising lifestyle-related diseases.

Modern medical technology improves diagnostics, therapy, patient care, and rehabilitation, increasing quality of life and efficiency in healthcare. The sector benefits from value growth in healthcare providers, rising treatment volumes, and trends in digitalization and AI.

This page offers insights and current asset management news from Bellevue Group AG.

The Medtech & Services sector is one of the most defensive healthcare segments with sustainable outperformance potential. Bellevue Medtech & Services is among the most successful funds in this area.

Bellevue joins the sponsors of the BIS.on WMS platform, developed by Dericon for Nord/LB. Over 100 Sparkassen adopted the securities management system within 18 months.

Bellevue Asset Management’s BB Entrepreneur Private strategy, focused on growth financing for unlisted Swiss mid-sized companies, completes its first successful closing at CHF 40 million.

Michel Keusch and Laurent Picard join as co-lead managers in the Entrepreneur team, working alongside lead manager Birgitte Olsen.

Investment values can fluctuate. Past performance does not guarantee future results. Potential investors should consult a tax specialist about tax implications for purchasing, holding, or selling investment products at their place of residence.